APIs and Excipients

Celonic Acquires Glycotope’s Biomanufacturing Facility

November 03, 2017

CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.

Catalent and Grid Therapeutics Form Immuno-Oncology Pact

November 02, 2017

The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.

Awards Recognize Industry Contributions

November 02, 2017

Industry experts were honored for business, scientific, and social contributions.

Growing Demand for Taste-Masking Technologies

November 02, 2017

Taste masking increases drug acceptability and medication adherence in pediatric, geriatric, and other special patient populations.

PTSM: Pharmaceutical Technology Sourcing and Management

Setting Safety Processes for Potentially Potent APIs

November 01, 2017

CDMOs sharpen skills for identifying API potency risks and establishing safety and handling procedures.

AbbVie and Alector Partner on Alzheimer’s Disease Immunotherapies

October 27, 2017

AbbVie will pay a $205-million upfront payment and have the option to develop and commercialize two antibody targets globally.

Roquette Opens New Asia Pacific Headquarters and Innovation Center in Singapore

October 26, 2017

The company has opened new facilities and an innovation center in Singapore, China that will focus on the development of plant-based products.

ABEC Develops Single-Use Bioreactor for Emergent Manufacturing Facility

October 25, 2017

ABEC, an equipment and engineering company, will provide a custom-made, single-use bioreactor to custom manufacturing firm, Emergent, for its Maryland manufacturing facility.

Cambrex Expands Large-Scale Manufacturing Capacity at Iowa Site

October 24, 2017

The API manufacturer has announced that it has completed the expansion of large-scale manufacturing capabilities at its Charles City, Iowa site.

FDA Approves Kite’s CAR-T Drug, Second Gene-Therapy in US

October 20, 2017

This approval marks the second gene therapy to be approved by FDA and the first to be approved for certain types of non-Hodgkin lymphoma.